Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...

The FDA has warned some counterfeit Ozempic products may still be available for purchase, here's what to know about the fake weight-loss drugs. ... but also the labeling and packaging it comes in.

Ozempic-side-effects-fda - Credit: Photo illustration by Mario Tama/Getty Images. ... While the reaction is new to Ozempic packaging, gastrointestinal side effects are common for GLP-1 medicines.

Health Canada has issued a recall for a lot of Ozempic after discovering that some units may have cracked glass in the medication packaging, which could lead to contamination or injury if used. The ...

Ozempic has been approved only for type 2 diabetics, and Wegovy has been approved only for patients with a BMI above 30, or 27 if they have a weight-related comorbidity like high blood pressure.

Ozempic — or any of the GLP-1 class of diet drugs that includes Wegovy and Mounjaro — hasn’t just changed our nation’s waistline. It’s changed the foods we eat, the ways we celebrate ...

Popular weight-loss and type 2 diabetes drugs such as Wegovy and Ozempic are typically taken as self-administered injections—a bearable albeit unpleasant jab to the abdomen or thigh. But drug ...

With prescriptions for semaglutide drugs, including Wegovy and Ozempic, on the rise, food sellers are increasingly fielding questions about the possibility of a significant shift in how — or how ...

You may have heard about Ozempic, a medicine for type 2 diabetes approved by the FDA in 2017. This medicine is for use with diet and exercise to improve control of blood glucose levels in people ...

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic ...

A new study adds to mounting evidence showing that drugs like Ozempic don’t just treat diabetes — they can also prevent it. The new paper, published Wednesday in The New England Journal of ...